Pricilla Hsue, MD
Professor of Medicine,
The UCSF School of Medicine
Co-Director,
Center for Vascular Excellence 
University of California, San Francisco

Monday, September 30, 2019
Noon – 1 p.m. CT
Stonewall Conference Rooms
625 N Michigan Ave
Chicago, IL 60611

Dr. Hsue’s research interest is in the pathogenesis, clinical manifestations, and treatment of cardiovascular disease and inflammation in HIV-infected patients. As co-director of the Center for Vascular Excellence at UCSF, Dr. Hsue has extensive experience in ultrasound imaging including assessment of carotid artery intima-media thickness and assessment of endothelial function using flow-mediated vasodilation of the brachial artery and has used both of these techniques to study HIV-infected individuals with the purpose of ascertaining the pathophysiology of HIV-related cardiovascular disease and the role of inflammation in this disease process. Dr. Hsue has published widely in the area of HIV-related cardiovascular disease and inflammation including high-impact publications in Circulation, JACC, JAMA Cardiology, and AIDS. Dr. Hsue established the HIV Cardiology Clinic at San Francisco General Hospital and is one of the few cardiologists internationally with clinical as well as research expertise in this area. She is PI of a multicenter clinical trial to evaluate the cardiovascular impact of low dose methotrexate in HIV and leads a single center clinical trial of IL-1β inhibition using canakinumab in HIV as well as a single center trial of PCSK9 inhibition in HIV.

RSVP Here:

[formidable id=”6″]